Houston officially has an innovative culinary mecca in the works. Courtesy of Houston Farmers Market

The massive effort to transform the Houston Farmers Market into one of the city's leading culinary attractions finally has a timeline. MLB Capital Partners, the local investment firm that purchased the almost 18-acre tract at the corner of Airline Drive and 610 in 2017, broke ground on the project Tuesday, August 6, with a goal of completing the work by late 2020.

"As the country's fourth-largest city and leading culinary capital, Houston is long overdue for a world-class market," said MLB Capital Partners managing principal Todd Mason in a statement. "We are thrilled to reinvigorate this local landmark into an experiential destination for both Houstonians and visitors to enjoy."

MLB's changes to the property will include "new climate-controlled spaces, shaded open-air market areas, restrooms, and common seating areas," according to a release. Better traffic flow and expanded parking areas will separate commercial traffic from pedestrians, and expanded facilities will accommodate a host of new merchants and food vendors. The market will remain open during the renovations.

James Beard Award-winning chef Chris Shepherd is serving as a culinary consultant on the project and will open a new concept at the market, which shouldn't come as a surprising considering Mason is also Shepherd's partner in Underbelly Hospitality. Other participants in the project include landscape architecture firm Clark Condon Associates, Studio RED Architects, Houston-based consulting firm Gunda Corporation, and Arch-Con Construction.

"We'll be doing something here," Shepherd tells CultureMap. "As far as what that is, I've narrowed it down to about 50 things."

Renovations to the market will include new greenspaces. Courtesy of Houston Farmers Market


Shepherd is also working with Mason to identify the vendors that will occupy the market's new stalls. While some have expressed concerns about the market losing its character, Mason told CultureMap in 2017 that he wants to preserve what people like about the market while enhancing the overall experience.

"When you really start talking to people about what they like, what they like is there's a lot of different cultures and there are things you can get and see there that you can't get anywhere else," Mason said. "We'll keep those tenants. I don't think we'll have to charge them much if any more rent. We'll still have an open air market with vendors selling directly to you. All of that experience will still be there, but it will be a cleaner, safer environment."

For his part, Shepherd sees the project as a positive development.

"I think it's amazing what's going on," he says. "I think, 10 years from now, you're going to look back and be like this was the moment where we changed the city a little bit . . . It is one of those defining things that will bring a lot of tourism over here."

------

This story originally appeared on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.